Clinical Trial Update: HPV Vaccine Reduced Dose [Phase 4]

View source ↗

Summary

Phase 4 trial from Emory University evaluating a reduced-dose human papillomavirus vaccine; recruitment is ongoing for HPV-related indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Cervical Cancer
• Genital Warts
• Human Papillomavirus Infection
• Oropharyngeal Cancer

Drugs mentioned

• HPV vaccine

Snippet

Sponsor: Emory University | Conditions: HPV | Phase 4 | Status: RECRUITING